Know What's Happening in BioTech

High‐Selective and Ultrafast Furfural Removal From Simulated Biomass Hydrolysates via a Sustainable MOF‐Based Strategy
NewsJan 19, 2026

High‐Selective and Ultrafast Furfural Removal From Simulated Biomass Hydrolysates via a Sustainable MOF‐Based Strategy

Researchers introduced MIL-53-TDC, a metal‑organic framework that removes furfural from simulated biomass hydrolysates with unprecedented speed and selectivity. The material combines size‑based molecular sieving with moderate hydrogen‑bonding to achieve 98% furfural removal and a static capacity of 424.6 mg g⁻¹, while leaving...

By Small (Wiley)
An Intracellular Antibody for Α-Synuclein Improves Motor Function in Aged Rats
BlogJan 19, 2026

An Intracellular Antibody for Α-Synuclein Improves Motor Function in Aged Rats

Researchers used an adeno‑associated virus to deliver the NAC32 intrabody into the substantia nigra of aged rats, achieving a marked reduction in α‑synuclein accumulation. The treatment restored tyrosine hydroxylase expression, raised striatal dopamine levels, and significantly improved locomotor performance without...

By Fight Aging!
Mechanisms of Aging in the Vasculature and Immune System in the Context of Hypertension
BlogJan 19, 2026

Mechanisms of Aging in the Vasculature and Immune System in the Context of Hypertension

The review highlights chronic inflammation as a central driver of vascular dysfunction in hypertension, emphasizing a feedback loop where immune dysregulation impairs hematopoiesis in the bone marrow, which in turn fuels further inflammation. It details how oxidative stress and endothelial...

By Fight Aging!
Accelerated & Breakthrough Save Time; Fast Track Doesn't
SocialJan 19, 2026

Accelerated & Breakthrough Save Time; Fast Track Doesn't

How much time do FDA expedited designations save? Accelerated approval and Breakthrough status save a statistically significant amount of time. But Fast track does not Investors should keep this in mind #learnbiotechinvesting #biotech #investing #BiotechPrometheus https://t.co/tmxBBt7Izi

By Biotech Investor
NICE Relents, Ending Postcode Access to Prostate Cancer Drug
NewsJan 19, 2026

NICE Relents, Ending Postcode Access to Prostate Cancer Drug

NICE has issued new guidance allowing abiraterone, both the Zytiga brand and generics, for men in England with high‑risk localized or locally advanced prostate cancer, aligning England with Wales and Scotland. The decision follows a patient‑led campaign and recent phase‑3...

By pharmaphorum
Raising Awareness: Understanding Dysplastic Nevi Through Video
NewsJan 19, 2026

Raising Awareness: Understanding Dysplastic Nevi Through Video

A new video campaign aims to raise public awareness of dysplastic nevi, the atypical moles that can signal heightened melanoma risk. The short film combines dermatologist interviews, animated lesion mapping, and real‑patient stories to illustrate visual cues for early detection....

By Bioengineer.org
Detecting Aflatoxins and Ochratoxin A in Feed
NewsJan 19, 2026

Detecting Aflatoxins and Ochratoxin A in Feed

A new wave of detection technologies is reshaping how aflatoxins and Ochratoxin A are identified in animal feed. Rapid immunoassays now deliver results in minutes, while high‑resolution LC‑MS/MS provides parts‑per‑billion quantification. Integrated sensor platforms enable on‑farm screening, helping producers meet...

By Bioengineer.org
'Skinny' Generic Vascepa Label Case Reaches US Supreme Court
NewsJan 19, 2026

'Skinny' Generic Vascepa Label Case Reaches US Supreme Court

The U.S. Supreme Court agreed to hear Amarin’s appeal against Hikma over the use of a “skinny label” for a generic version of Vascepa, the omega‑3 drug that accounts for roughly $215 million of Amarin’s annual revenue. Hikma’s generic entered the...

By pharmaphorum
LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026
NewsJan 19, 2026

LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026

LOTTE Biologics is ramping its Syracuse ADC hub for 2026 while extending a unified global quality culture across its organization. The company emphasizes a proactive contamination‑control strategy that relies on closed, functionally closed and single‑use systems, validated cleaning, and rigorous...

By BioSpace
Report: U.S. Life Sciences Job Market Report Q4 2025
NewsJan 19, 2026

Report: U.S. Life Sciences Job Market Report Q4 2025

BioSpace’s Q4 2025 U.S. Life Sciences Job Market Report shows early signs that biopharma hiring is stabilizing after a turbulent period. Job postings increased modestly, while layoffs slowed markedly, and hiring sentiment edged higher heading into 2026. The report highlights...

By BioSpace
BCOR Mutations Reveal Target for AML Treatment
NewsJan 19, 2026

BCOR Mutations Reveal Target for AML Treatment

A recent study identified mutations in the BCL6 corepressor (BCOR) as a driver in a subset of acute myeloid leukemia (AML) patients. Approximately 12% of newly diagnosed AML cases harbor BCOR alterations, which render the leukemia cells dependent on the...

By Bioengineer.org
Understanding Acute-on-Chronic Liver Failure: Mechanisms & Care
NewsJan 19, 2026

Understanding Acute-on-Chronic Liver Failure: Mechanisms & Care

Acute‑on‑chronic liver failure (ACLF) is a severe syndrome where an acute hepatic insult precipitates rapid decompensation in patients with existing chronic liver disease, leading to high short‑term mortality. Recent studies highlight a triad of inflammatory drivers—damage‑associated molecular patterns, gut‑derived microbial...

By Bioengineer.org
After the JPM Hype, a Reality Check: Why Your 2026 Strategy Hinges on Your Manufacturing Toolkit
NewsJan 19, 2026

After the JPM Hype, a Reality Check: Why Your 2026 Strategy Hinges on Your Manufacturing Toolkit

After the J.P. Morgan Healthcare Conference, biotech firms face a reality check: manufacturing, not just discovery, will determine whether 2026 promises are fulfilled. The article argues that flexible CDMO toolkits, combining legacy platforms like AGC Biologics’ CHEF1 with high‑speed systems...

By BioSpace
Autonomous Labs Free Scientists From Bench Work
SocialJan 19, 2026

Autonomous Labs Free Scientists From Bench Work

Great article from @packyM and @evanbeard -- I agree with this distinction between automation and autonomy. We've been working on autonomy with our autonomous labs at @Ginkgo -- much needed to get scientists off the lab bench, more in...

By Jason Kelly
Left Behind Parents in Rural West Bengal: Insights
NewsJan 19, 2026

Left Behind Parents in Rural West Bengal: Insights

A new study by Dakua and Lhungdim documents the growing plight of left‑behind parents in rural West Bengal. It finds a sharp rise in solitary living arrangements, with many elderly falling below the poverty line and women bearing disproportionate hardship....

By Bioengineer.org
Ferroptosis in Neurological Diseases: Moving Towards Therapeutic Intervention
NewsJan 19, 2026

Ferroptosis in Neurological Diseases: Moving Towards Therapeutic Intervention

Recent advances have clarified how ferroptosis—a regulated, iron‑dependent form of lipid peroxidation—contributes to a spectrum of neurological disorders, including ischemic stroke, Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Mechanistic studies highlight the central roles of glutathione peroxidase 4 (GPX4), ferroptosis suppressor...

By Nature (Biotechnology)
Single-Cell Characterization of the Adult Male Hippocampus Suggests a Prominent, and Cell-Type Specific, Role for Nrgn and Sgk1 in Response...
NewsJan 19, 2026

Single-Cell Characterization of the Adult Male Hippocampus Suggests a Prominent, and Cell-Type Specific, Role for Nrgn and Sgk1 in Response...

Researchers generated the largest single‑cell RNA‑sequencing atlas of the adult male mouse posterior hippocampus, profiling 125,896 cells from wild‑type and conditional glucocorticoid‑receptor (GR) or mineralocorticoid‑receptor (MR) knockouts under acute social stress. The analysis identified neurogranin (Nrgn) as a robust marker...

By Nature (Biotechnology)
Spatiotemporal Targeting of Messenger RNA Lipid Nanoparticles to the Endometrium for the Treatment of Reproductive Disorders
NewsJan 19, 2026

Spatiotemporal Targeting of Messenger RNA Lipid Nanoparticles to the Endometrium for the Treatment of Reproductive Disorders

Researchers engineered lipid nanoparticles (LNPs) functionalized with an RGD peptide directly attached to the lipid tail, enabling precise mRNA delivery to the uterine endometrium during the window of implantation. In mouse models, the RGD‑LNPs achieved a 3,900‑fold increase in uterine...

By Nature Nanotechnology
Fibroblast Activation in Failing Hearts: Location Matters
NewsJan 18, 2026

Fibroblast Activation in Failing Hearts: Location Matters

Researchers have discovered that fibroblast activation in failing hearts is highly region‑specific, with the epicardial and subendocardial layers showing distinct molecular signatures. Spatial transcriptomics revealed that activated fibroblasts near scar tissue express profibrotic genes, while those in remote zones remain...

By Bioengineer.org
Low Air Pressure Clears Senescent Cells, Extends Mouse Lifespan
SocialJan 18, 2026

Low Air Pressure Clears Senescent Cells, Extends Mouse Lifespan

Intermittent bouts of low air pressure prevent hair loss, weight gain, osteoporosis, and extend the lifespan of mice. Ascribed to selective lysosomal killing of senescent cells. Could aerobic exercise or high altitudes mimic this effect? 🧵 https://doi.org/10.1038/s41551-025-01584-5

By David Sinclair
Scientists Just Discovered Something Horrid About Those Disposable Coffee Cups You’ve Been Slurping
NewsJan 18, 2026

Scientists Just Discovered Something Horrid About Those Disposable Coffee Cups You’ve Been Slurping

A new study from Griffith University shows that disposable coffee cups release large quantities of microplastics when filled with hot liquids. Experiments with 400 cups found particle emissions ranging from a few hundred to over eight million per liter, with...

By Futurism BioTech
Meta‑Contrarian Biotech Thesis: Consensus Locally, Ignored Globally
SocialJan 18, 2026

Meta‑Contrarian Biotech Thesis: Consensus Locally, Ignored Globally

Great article altogether by @KevinLMak on how he arrives at an $ABVX bull thesis as a generalist. You should read the whole thing, but the lines below are far too good not to share: 👉"The result is an unusual dynamic....

By Adam May
AI-Powered Screening for Low Bone Mass in X-Rays
NewsJan 18, 2026

AI-Powered Screening for Low Bone Mass in X-Rays

A new artificial‑intelligence algorithm can identify low bone mass, a precursor to osteoporosis, directly from routine X‑ray images. The system was trained on over 200,000 annotated radiographs and achieved more than 90% sensitivity in clinical validation. By flagging at‑risk patients...

By Bioengineer.org
Endothelial Dysfunction Tied to Post-COVID-19 Symptoms
NewsJan 18, 2026

Endothelial Dysfunction Tied to Post-COVID-19 Symptoms

Recent clinical research links persistent endothelial dysfunction to the constellation of post‑COVID‑19 symptoms, often called long COVID. The study measured vascular biomarkers and flow‑mediated dilation in recovered patients, finding significant microvascular impairment months after infection. Elevated adhesion molecules such as...

By Bioengineer.org
New Fluorescent Labels Offer Clearer, High-Contrast Imaging of Live Cell Processes
NewsJan 18, 2026

New Fluorescent Labels Offer Clearer, High-Contrast Imaging of Live Cell Processes

Researchers at the Institute of Organic Chemistry and Biochemistry (IOCB) in Prague have created fluorogenic triazinium fluorescent labels that light up only when bound to specific cellular targets. The probes suppress background fluorescence, eliminating the need for repeated washing steps...

By Phys.org – Biotechnology
MEK Inhibitor Trametinib Boosts
SocialJan 18, 2026

MEK Inhibitor Trametinib Boosts

Trametinib is an approved drug for melanoma. It inhibits MEK1/2 thereby shifting cells away from “grow at all costs” to maintenance & repair🐁Trimetaprib extends lifespan ~15% & with rapamycin a whopping 30%

By David Sinclair
Tracking Fungal Pathogen Evolution Through Comparative Genomics
NewsJan 18, 2026

Tracking Fungal Pathogen Evolution Through Comparative Genomics

A new study leverages comparative genomics to map the evolutionary trajectories of major fungal pathogens affecting crops and humans. By sequencing hundreds of isolates, researchers identified dozens of previously unknown virulence factors and demonstrated how horizontal gene transfer accelerates adaptation....

By Bioengineer.org
Dormant Cancer Cells Evade Immune System by Changing Shape in Mouse Model
NewsJan 18, 2026

Dormant Cancer Cells Evade Immune System by Changing Shape in Mouse Model

Researchers at Memorial Sloan Kettering published a study in Nature Cancer showing that TGFβ drives disseminated lung adenocarcinoma cells through a full epithelial‑to‑mesenchymal transition before they adopt a rounded, low‑tension shape. This biomechanical softening, mediated by the actin‑severing protein gelsolin,...

By GEN (Genetic Engineering & Biotechnology News)
Cytokines and Estradiol: Age and Reproductive Impact
NewsJan 18, 2026

Cytokines and Estradiol: Age and Reproductive Impact

Recent research links estradiol levels to age‑dependent cytokine patterns, revealing that hormonal shifts drive immune modulation throughout a woman’s reproductive lifespan. The study shows estradiol suppresses pro‑inflammatory cytokines such as IL‑6 while low estradiol in post‑menopause coincides with heightened TNF‑α....

By Bioengineer.org
Biotech Pre‑funded Warrants Raise Cash, Delay Dilution
SocialJan 18, 2026

Biotech Pre‑funded Warrants Raise Cash, Delay Dilution

Since most biotechs aren't profitable they often use warrants (including pre-funded) to raise capital while mitigating short term dilution But what is a warrant and what are their implications? #learnbiotechinvesting #biotech #investing #BiotechPrometheus A warrant is a security that gives the...

By Biotech Investor
Stop Wasting Hours Matching Sample IDs Across Assays
SocialJan 18, 2026

Stop Wasting Hours Matching Sample IDs Across Assays

1/ How many hours do bioinformaticians lose matching sample IDs across assays? Too many. And it’s avoidable. Let’s talk about why this happens—and how to stop it. https://t.co/ZIcF1bUzFF

By Ming Tang
Weekly Reads: FDA Politics, Lineage Cell Update, Tuft Cells & Cancer, Neuron Mitochondrial Transfer, Dead Celeb Genomics
BlogJan 18, 2026

Weekly Reads: FDA Politics, Lineage Cell Update, Tuft Cells & Cancer, Neuron Mitochondrial Transfer, Dead Celeb Genomics

The blog spotlights a surge of political influence at the FDA, noting RFK Jr.'s role in reshaping policy and even removing a warning on dubious autism therapies. It highlights Lineage Cell’s receipt of a gene‑edited hypoimmune iPSC line from Factor Bioscience,...

By The Niche
Linking Popularity, Oxytocin Gene, and Emotional Insights
NewsJan 18, 2026

Linking Popularity, Oxytocin Gene, and Emotional Insights

On January 18, 2026 Bioengineer.org published a suite of research highlights spanning immunotherapy, dermatology, bariatric health, drug policy, and alternative diesel fuels. The articles report that Actinomyces signals improve lung‑cancer immunotherapy response, while kaempferol protects skin cells from UVB damage....

By Bioengineer.org
Casein-Manganese Ferrite Nanostructures Extract Carotenoids
NewsJan 18, 2026

Casein-Manganese Ferrite Nanostructures Extract Carotenoids

Researchers have engineered casein‑manganese ferrite nanostructures that act as magnetic adsorbents for carotenoid extraction. The hybrid combines biodegradable casein with Mn‑ferrite’s magnetic responsiveness, enabling rapid separation and high recovery rates. Laboratory tests showed up to 85% yield from tomato and...

By Bioengineer.org
Disarming Antibiotic-Resistant Bacteria That Prevent Healing in Chronic Wounds
NewsJan 17, 2026

Disarming Antibiotic-Resistant Bacteria That Prevent Healing in Chronic Wounds

An international team led by NTU Singapore uncovered that Enterococcus faecalis impairs chronic wound healing through extracellular electron transport (EET) that generates reactive oxygen species (ROS). The ROS activates the unfolded protein response in keratinocytes, halting cell migration needed for...

By GEN (Genetic Engineering & Biotechnology News)
AI Tools Speed Development of Antibody Probes to See Activity Inside Living Cells
NewsJan 17, 2026

AI Tools Speed Development of Antibody Probes to See Activity Inside Living Cells

Researchers at Colorado State University used AI tools to convert conventional antibodies into intracellular “intrabodies” that light up specific histone modifications. By leveraging AlphaFold2 and ProteinMPNN, the team reduced design cycles to five candidates and achieved a 70% success rate,...

By Phys.org – Biotechnology
Two-Step Genome Editing Enables Creation of Full-Length Humanized Mouse Models
NewsJan 17, 2026

Two-Step Genome Editing Enables Creation of Full-Length Humanized Mouse Models

Researchers at the University of Tokyo unveiled TECHNO, a two‑step genome‑editing platform that swaps entire mouse loci for full‑length human genes exceeding 200 kb. By combining CRISPR/Cas9‑mediated landing‑site creation with BAC‑driven integration, the method achieves high‑efficiency replacement of coding and regulatory...

By Phys.org – Biotechnology
Biotech Success Now Hinges on De‑risking and Speed
SocialJan 17, 2026

Biotech Success Now Hinges on De‑risking and Speed

We asked the biotwit some interesting industry questions. The answers were telling... 5 takeaways from last week’s biotech polls: 1️⃣ When efficacy ceilings are hit, risk wins. Safety, tolerability, and long-term risk profile now beat novelty and precision once drugs work “well enough.” 2️⃣...

By BowTiedBiotech
DUD‑E Bias Inflates Deep‑learning Virtual Screening Results
SocialJan 17, 2026

DUD‑E Bias Inflates Deep‑learning Virtual Screening Results

Hidden bias in the DUD-E dataset leads to misleading performance of deep learning in structure-based virtual screening https://t.co/NEAe3zdQrq

By Ming Tang
JPM Recap; Mirador Raises $250M; Genentech’s PBM Shift; and More
NewsJan 17, 2026

JPM Recap; Mirador Raises $250M; Genentech’s PBM Shift; and More

The JPMorgan Healthcare Conference (JPM26) highlighted a surge in biotech financing, with several firms announcing sizable funding rounds. Mirador Therapeutics disclosed a $250 million Series B raise to accelerate its gene‑therapy platform. Genentech revealed plans to bring its pharmacy‑benefit‑manager (PBM) operations in‑house,...

By Endpoints News
AI Diabetes Prevention Program Matches Human-Led Outcomes
SocialJan 17, 2026

AI Diabetes Prevention Program Matches Human-Led Outcomes

#AI-Powered Diabetes Prevention Program Shows Similar Benefits to Those Led by People by Rebekah Mikeasky @HubJHU Learn more: https://t.co/4Xs9wCHAPf #ArtificialIntelligence #MachineLearning #ML #MedTech #HealthTech https://t.co/OryFWrOc5O

By Ronald van Loon
US Drops Rotavirus Vaccine Despite Preventable Illness
SocialJan 17, 2026

US Drops Rotavirus Vaccine Despite Preventable Illness

In affluent countries with accessible healthcare, most kids survive #rotavirus infection. But that doesn't mean kids & their families should have to go through a nasty illness. Rotavirus vaccine was one of those recently dropped from the US "recommended for...

By Helen Branswell
A-Maze-Ox: Adjustable Oxygenator for Preterm Infants
NewsJan 17, 2026

A-Maze-Ox: Adjustable Oxygenator for Preterm Infants

The A‑Maze‑Ox is a new adjustable oxygenator designed specifically for preterm infants in neonatal intensive care units. Its micro‑fluidic membrane technology allows clinicians to fine‑tune oxygen delivery in real‑time, minimizing both hypoxia and hyperoxia. Early multicenter trials reported a 15%...

By Bioengineer.org
T‑bet+ CD8 T Cells Predict Neoadjuvant PD‑1 Response
SocialJan 17, 2026

T‑bet+ CD8 T Cells Predict Neoadjuvant PD‑1 Response

Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade https://t.co/VSwMpdqjqO https://t.co/DXc8P28oIZ

By Ming Tang
One Year In, Code Works—Beware Self‑Deception
SocialJan 17, 2026

One Year In, Code Works—Beware Self‑Deception

1/ A year into bioinformatics, your code starts to work. But that’s also when it gets dangerous. Because now you can fool yourself. https://t.co/7QCMSpI30A

By Ming Tang
Decoding pH‐Driven Phase Transition of Lipid Nanoparticles
NewsJan 17, 2026

Decoding pH‐Driven Phase Transition of Lipid Nanoparticles

Researchers applied constant‑pH molecular dynamics to the Comirnaty lipid nanoparticle formulation, uncovering a dramatic pKa shift for the ionizable aminolipid ALC‑0315. The intrinsic pKa of 9.3 in water drops to an apparent 4.9 within the LNP, with surface regions remaining...

By Small (Wiley)
IBRX Surge Fueled by 700% Revenue Forecast, Not Anecdote
SocialJan 17, 2026

IBRX Surge Fueled by 700% Revenue Forecast, Not Anecdote

$IBRX is trending on the TL - but the +40% pop more likely driven by prelim 2025 net product revenue of ~$113M, up ~700% y/y and not this tiny N CD19 CAR-NK + ritux anecdote in a rare lymphoma. https://t.co/64wkMTGX9v

By BowTiedBiotech
SIAE Variant Linked to Autoimmunity Lacks Control Evidence
SocialJan 17, 2026

SIAE Variant Linked to Autoimmunity Lacks Control Evidence

1/ Eight patients had a genetic variant. Zero controls did. That 2010 Nature paper claimed SIAE variants increased autoimmune risk 8-fold. The mouse data was clean. The functional assays checked out. https://t.co/tFKXjXEr1y

By Ming Tang
Plan Biotech Catalysts Early to Capture Stock Moves
SocialJan 17, 2026

Plan Biotech Catalysts Early to Capture Stock Moves

Investors should know WHAT will move a stock and WHEN, especially in biotech with the outsized moves. Build your catalyst calendar ahead of time. You won't have time to thoughtfully analyze the data when it hits #learnbiotechinvesting #biotech #investing #BiotechPrometheus https://t.co/iFc6oc4jll

By Biotech Investor